Evofem Announces Issuance of U.S. Patent Covering Phexxi® Composition of Matter

— Issuance of U.S. Patent No. 11,439,610 Further Strengthens Evofem’s Intellectual Patent Portfolio — — Newly Issued Patent Expected to Provide Protection for Phexxi into At Least 2033 — SAN DIEGO, Sept. 23, 2022 /PRNewswire/ — Evofem Biosciences (OTCPK: EVFM) today announced that…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks